Cell & Gene Therapy Asia 2019 - Kobe Japan, 11-12 November 2019

SelectBIO is pleased to welcome you to the Second Annual Cell & Gene Therapy Asia 2019 which will be held in Kobe, Japan on November 11-12, 2019.

This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application and technologies for gene therapy.

The conference addresses the whole ecosystem of Cell & Gene Therapy and 3D-Bioprinting with a focus on 3D-Culture, Organoids, Bioprinting and Technology Platforms being developed to bring cell therapy, gene therapy and regenerative medicine to the clinic.

In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.

With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Cell & Gene Therapy Asia 2019.

SelectBIO is honored that Professor Norio Nakatsuji, Professor Emeritus Kyoto University will be leading the conference as Chairman and invites young scientists to submit poster abstracts to the conference and participate in the conference.

Find out more at website link below.


 

Asia Research News proudly partners with this event. If you attend, keep an eye out for print copies of the Asia Research News magazine!

Asia Research News partners with more than 80 R&D conferences and events all over the world, helping raise awareness about the events and providing complimentary copies of Asia Research News magazine to delegates. Learn more about media partnerships or participating in the magazine.  


 

From 11 Nov 2019
Until 12 Nov 2019
Add to Calendar
Kobe
News topics: 
Academic discipline: